Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.47 USD | -1.22% | -6.37% | -37.25% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Neutral |
Resistance | 9.030 | 10.94 | 17.02 |
Spread/Res. | -28.35% | -40.86% | -61.99% |
Spread/Supp. | +0.15% | +0.15% | +58.19% |
Support | 6.460 | 6.460 | 4.090 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- NPCE Stock
- Charts NeuroPace, Inc.